Research confirms the power of marijuana in pain management and treating substance abuse. Big Pharma should be worried. Read More
Analyst Articles
These mega-cap tech stocks account for about 60% of the S&P 500's strong rise over the past 12 months. Can the seven stay in the saddle? Read More
Leverage can be useful, if applied properly. Here’s a look at certain types of loans that are rip-offs. Read More
Jobs growth and tech profits paint a rosy, not red-hot, picture. We parse the latest economic data. Read More
It pays to keep an eye on the bond market, which represents a collective wisdom about the future direction of not just bonds but also stocks. Read More
Despite the rise of a wide variety of new cannabis products, the most popular form remains traditional, smokeable flower. Read More
As expected, the U.S. central bank Wednesday kept interest rates on hold at 5.25% - 5.50%. Now, all eyes are on the timing of future cuts. Read More
From China to the Middle East to Eastern Europe, international events are casting a shadow over markets. And yet, America brings good news. Read More
Democrats tend to favor legalizing cannabis, but a growing number of Republicans also are embracing marijuana legal reform. Read More
The recession fearmongers got it wrong. Jerome Powell's Fed has engineered a soft landing for the economy, creating a tailwind for stocks. Read More